Page 240 - Clinical Immunology_ Principles and Practice ( PDFDrive )

CHaPter 14 The Microbiota in Immunity and Inflammation 219

27. Feller M, Huwiler K, Schoepfer A, et al. Long-term antibiotic treatment 39. Goldszmid RS, Dzutsev A, Trinchieri G. Host immune response to
for Crohn’s disease: systematic review and meta-analysis of infection and cancer: unexpected commonalities. Cell Host Microbe
placebo-controlled trials. Clin Infect Dis 2010;50:473–80. 2014;15:295–305.
28. Joossens M, Huys G, Cnockaert M, et al. Dysbiosis of the faecal 40. de Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers
microbiota in patients with Crohn’s disease and their unaffected relatives. attributable to infections in 2008: a review and synthetic analysis. Lancet
Gut 2011;60:631–7. Oncol 2012;13:607–15.
29. Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have 41. Parkin DM. The global health burden of infection-associated cancers in
shaped the genetic architecture of inflammatory bowel disease. Nature the year 2002. Int J Cancer 2006;118:3030–44.
2012;491:119–24. 42. Dejea C, Wick E, Sears CL. Bacterial oncogenesis in the colon. Future
30. Philpott DJ, Sorbara MT, Robertson SJ, et al. NOD proteins: regulators of Microbiol 2013;8:445–60.
inflammation in health and disease. Nat Rev Immunol 2014;14:9–23. 43. Viaud S, Saccheri F, Mignot G, et al. The intestinal microbiota modulates
31. Ramanan D, Tang MS, Bowcutt R, et al. Bacterial sensor Nod2 prevents the anticancer immune effects of cyclophosphamide. Science
inflammation of the small intestine by restricting the expansion of the 2013;342:971–6.
commensal Bacteroides vulgatus. Immunity 2014;41:311–24. 44. Findley K, Oh J, Yang J, et al. Topographic diversity of fungal and
32. Wheeler ML, Limon JJ, Bar AS, et al. Immunological consequences of bacterial communities in human skin. Nature 2013;498:367–70.
intestinal fungal dysbiosis. Cell Host Microbe 2016;19:865–73. 45. Oh J, Conlan S, Polley EC, et al. Shifts in human skin and nares
33. Cadwell K, Patel KK, Maloney NS, et al. Virus-plus-susceptibility gene microbiota of healthy children and adults. Genome Med 2012;4:77.
interaction determines Crohn’s disease gene Atg16L1 phenotypes in 46. Nakamizo S, Egawa G, Honda T, et al. Commensal bacteria and
intestine. Cell 2010;141:1135–45. cutaneous immunity. Semin Immunopathol 2015;37:73–80.
34. Yang JY, Kim MS, Kim E, et al. Enteric viruses ameliorate gut 47. Morizane S, Gallo RL. Antimicrobial peptides in the pathogenesis of
inflammation via Toll-Like Receptor 3 and Toll-Like Receptor 7-mediated psoriasis. J Dermatol 2012;39:225–30.
interferon-β production. Immunity 2016;44:889–900. 48. Cho SH, Strickland I, Boguniewicz M, et al. Fibronectin and fibrinogen
35. Ridaura VK, Faith JJ, Rey FE, et al. Gut microbiota from twins discordant contribute to the enhanced binding of Staphylococcus aureus to atopic
for obesity modulate metabolism in mice. Science 2013;341:1241214. skin. J Allergy Clin Immunol 2001;108:269–74.
36. Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut 49. Bassis CM, Erb-Downward JR, Dickson RP, et al. Analysis of the upper
microbiome with increased capacity for energy harvest. Nature respiratory tract microbiotas as the source of the lung and gastric
2006;444:1027–31. microbiotas in healthy individuals. MBio 2015;6:e00037.
37. Boulange CL, Neves AL, Chilloux J, et al. Impact of the gut microbiota on 50. O’Dwyer DN, Dickson RP, Moore BB. The lung microbiome, immunity,
inflammation, obesity, and metabolic disease. Genome Med 2016;8:42. and the pathogenesis of chronic lung disease. J Immunol
38. Lee YK, Menezes JS, Umesaki Y, et al. Proinflammatory T-cell responses 2016;196:4839–47.
to gut microbiota promote experimental autoimmune encephalomyelitis.
Proc Natl Acad Sci USA 2011;108(Suppl. 1):4615–22.